Cognition and Patients With Lung Cancer
NCT07160751
Summary
Cognitive complaints in patients treated for cancer can impact their quality of life. Studies show that these cognitive complaints may have multifactorial origins and appear at different stages of the care pathway. In a population of patients treated for confirmed localized non-small cell lung cancer (NSCLC), this study aims to detect and monitor the onset of cognitive complaints over time. The timing of the complaints during the treatment, the cognitive functions affected (memory, attention, concentration…), as well as the perceived intensity of the discomfort, will be examined. The study also explores the influence of co-factors such as mood, fatigue, socio-cultural status, and level of social vulnerability on these cognitive complaints.
Eligibility
Inclusion Criteria: * Adult patient aged 18 to 74 years * Suspected or confirmed localized and operable non-small cell lung cancer (NSCLC) * Surgical treatment with or without perioperative systemic medical therapy * Ability to independently complete self-questionnaires via the Cleanweb platform * Patients with access to a phone, tablet, or computer at home to complete the electronic self-questionnaires. Exclusion Criteria: * Known pre-existing cognitive disorders * Presence on the day of inclusion of one or more factors causing mental confusion: electrolyte imbalances, renal failure, hepatic failure, infections, bladder distension, fecal impaction * Known psychiatric or neurological diseases (e.g., multiple sclerosis, Parkinson's disease, dementia, stroke, traumatic brain injury with loss of consciousness) * Current use of neuroleptic treatments * History of cancer treatment within the past 10 years * Fibromyalgia * Individuals who cannot read French or are not French-speaking * Patients who have never attended school
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07160751